Metabolic Tumor Volume on 18-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Marker of Survival in Patients With Locally Advanced or Metastatic Neuroendocrine Neoplasms Treated With 177Lutetium-DOTA-Octreotate Peptide Receptor Radionuclide Therapy.

Autor: De Silva, Madhawa K., Chan, David L. H., Bernard, Elizabeth J., Conner, Alice J., Mascall, Sophie L., Bailey, Dale L., Roach, Paul J., Clarke, Stephen J., Diakos, Connie I., Pavlakis, Nick, Schembri, Geoff
Zdroj: Pancreas; Aug2024, Vol. 53 Issue 7, pe560-e565, 6p
Databáze: Complementary Index